News & Events

  • 2nd RNA- Targeted Drug Discovery Summit 2019

    When: Dec. 3rd, 2019 to Dec. 4th, 2019
    Where: Boston, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2nd RNA- Targeted Drug Discovery Summit 2019. Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will also participate with other experts as part of the “Targeting RNA with Small Molecules to Capture the Therapeutic Opportunities” panel.

    With numerous approaches emerging that demonstrate genuinely viable efficacy in targeting RNA, the 2nd RNA- Targeted Drug Discovery Summit is the only industry and translational focused conference dedicated to advancing pioneering RNA targeted small molecule therapeutics. For the 2nd year, at this event KOLs and RNA pioneers join to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic, delve into the exciting field of epitranscriptomics and stimulate discussion on how to successfully target RNA via RNA- modifying enzymes and interfering with RNA-protein interactions.

    Download Press Release »

    Visit the conference website »

  • Targeting RNA

    When: Nov. 26th, 2019 to Nov. 27th, 2019
    Where: Frankfurt, Germany

    Anima Biotech has been invited to present a talk on novel targets for small molecules between transcription and translation for lung fibrosis where they will discuss the discovery of lung-specific modulators of collagen translation and give insights into its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the Targeting RNA Europe Congress 2019. Dr. Iris Alroy, Vice President of R&D of Anima Biotech, will also participate in a roundtable discussion on “Discussing RNA Functionality Issues such as Selectivity, Binding, Stability and Specificity” and in the “Treating the Unmet Need: Unleashing the RNA Space With Small Molecules” panel.

    The Targeting RNA Congress explores the ‘undruggable’ RNA space and showcases the latest advancements in modulation of RNA directly with small molecules and through epigenetics. The meeting brings together academic and industry leaders who are building platforms to identify and validate targets in order to assess disease relevance approaches in the RNA world.

    Visit the conference website »

  • BIO-Europe

    When: Nov. 11th, 2019 to Nov. 13th, 2019
    Where: Hamburg, Germany

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 25th Annual BIO-Europe International Partnering Conference.

    BIO-Europe is Europe’s largest life science partnering conference offering countless opportunities to engage with global life science partners. This event features workshops and panels discussing the latest industry trends in biotech and pharma as well as company presentations and one-on-one partnering meetings.

    Download Press Release »

    Visit the conference website »

  • BIO Investor Forum

    When: Oct. 22nd, 2019 to Oct. 23rd, 2019
    Where: San Francisco, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2019 BIO Investor Forum.

    The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2020. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.

    Download Press Release »

    Visit the conference website »

  • BioJapan 2019

    When: Oct. 9th, 2019 to Oct. 11th, 2019
    Where: Yokohama, Japan

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2019 BioJapan World Business Forum. 

    BioJapan is Asia’s premier partnering event for the global biotechnology industry. BioJapan has been influential in furthering interaction between Japanese and global companies and advancing new business opportunities for nearly two decades. BioJapan draws in top business development, licensing, alliance management professionals, R&D personnel, and biotech company executives from around the world. 

    Download Press Release »

    Visit the conference website »

  • 19th Annual Biotech in Europe Forum Hosted by Sachs Associates

    When: Sep. 25th, 2019 to Sep. 26th, 2019
    Where: Basel, Switzerland

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 19th Annual Biotech in Europe Forum hosted by Sachs Associates. Yochi Slonim, Co-founder and Chief Executive Offer of Anima Biotech, will also participate on a “Platform Technologies & Novel Therapeutics” panel.

    The Biotech in Europe Forum is the leading international stage for those interested in investing and partnering in the biotech industry. This event unites companies of all stages with leading investors, analysts, money managers and pharma licensing executives. Sachs estimates over 700 delegates and over 100 presenting companies, and 30+ pitches by seed companies.

    Download Press Release »

    Visit the conference website »

  • Inaugural RNA as a Drug Target Program as Part of the 17th Annual Discovery on Target Conference

    When: Sep. 18th, 2019 to Sep. 19th, 2019
    Where: Boston, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that specifically control mRNA translation during the 17th Annual Discovery on Target Conference in the Inaugural RNA as a Drug Target Program.

    The Discovery on Target conference series is the industry’s preeminent event on novel drug targets and technologies. The RNA as a Drug Target program allows scientific leaders and biotech executives from around the world to collaborate about expanding the boundaries of druggable targets.

    Download Press Release »

    Visit the conference website »

  • 12th Annual BioPharm America International Partnering Conference

    When: Sep. 11th, 2019 to Sep. 12th, 2019
    Where: Boston, USA

    Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that specifically control mRNA translation during the 12th Annual BioPharm America International Partnering Conference.

    BioPharm America propels the future of drug development by bringing attendees unequaled value and unparalleled access to global decision makers in an elevated format that highlights innovation. The conference allows registrants to meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic partnerships.

    Download Press Release »

    Visit the conference website »

  • 2019 BIO International Convention

    When: Jun. 3rd, 2019 to Jun. 6th, 2019
    Where: Philadelphia, USA

    Anima Biotech has been invited to present an overview of its business and strategy during the 2019 BIO International Convention.

    The BIO International Convention is packed with the latest trends, technologies, companies and breakthrough ideas in biotech and pharma. The convention now boasts more than 1,800 exhibiting companies and delegations from 67 countries and hosts a variety of activities and provides opportunities to learn more about how attendees can help fuel the next big breakthrough.

    Download Press Release »

    Visit the conference website »

  • European High Content Screening User Group Meeting

    When: May. 16th, 2019 to May. 17th, 2019
    Where: Barcelona, Spain

    Anima Biotech has been invited to present about the discovery of Protein Synthesis Modulators of "Undruggable" Targets using its Translation Control Therapeutics platform during the European High Content Screening User Group Meeting.

    The European High Content Screening User Group Meeting provides a unique opportunity for users to appreciate the broad diversity of HCS applications; gain insights into new workflow solutions; share their experience, discuss challenges and learn about technology updates.

Pages